Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events — A meta-analysis

This publication has 25 references indexed in Scilit:

• Comparison of Different Methods to Evaluate the Effect of Aspirin on Platelet Function in High-Risk Patients With Ischemic Heart Disease Receiving Dual Antiplatelet Treatment
  American Journal of Clinical Pathology, 2007
• Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR)
  Blood Coagulation & Fibrinolysis, 2007
• Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review
  American Heart Journal, 2007
• Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
  Journal of Thrombosis and Haemostasis, 2006
• Usefulness of Aspirin Resistance After Percutaneous Coronary Intervention for Acute Myocardial Infarction in Predicting One-Year Major Adverse Coronary Events
  The American Journal of Cardiology, 2006
• High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome
  Journal of Thrombosis and Haemostasis, 2006
• Aspirin resistance: position paper of the Working Group on Aspirin Resistance
  Journal of Thrombosis and Haemostasis, 2005
• Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?
  American Heart Journal, 2004
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Development of aspirin resistance in persons with previous ischemic stroke.
  Stroke, 1994